Patent · US Expired

2-[N-(2'-Chlo ro-4'-methyl-thienyl-3')-N-(cyclopropyl-methyl)-amino]-2-imidazoline and salts thereof

US4215133A · kind A · utility

6Cited by

2References

3Claims

0Family size

Assignee

Boehringer Ingelheim GmbH · DE

Inventors

Helmut Stahle
Herbert Koppe · Ingelheim am Rhein, DE
Werner Kummer · Ingelheim am Rhein, DE
Walter Kobinger · Wien, AT
Christian Lillie · Wien, AT
Ludwig Pichler · Wien, AT

Key dates

Filing date	Jul 5, 1979
Grant date	Jul 29, 1980
Priority date	—
Expiry date	Jul 5, 1999

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

2-[N-(Cyclopropyl-methyl)-N-(2'-chloro-4'-methyl-thienyl-3')-amino]-2-imida zoline and non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds are useful as bradycardiacs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.